Ahmet Cingoz

Beykoz, 34820, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Genetically engineered human cell-based microrobots for selective cancer cell death.

Genetically engineered human cell-based microrobots for selective cancer cell death.

Journal: Science advances

Published: April 29, 2026

Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.

Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 04, 2025

Editorial Expression of Concern: Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization.

Editorial Expression of Concern: Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization.

Journal: Oncogene

Published: July 23, 2024

Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.

Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.

Journal: Experimental & molecular medicine

Published: April 18, 2024

Lymphatic Vessels Accompanying Dorsal and Basal Dural Sinuses in the Human Brain.

Lymphatic Vessels Accompanying Dorsal and Basal Dural Sinuses in the Human Brain.

Journal: Journal of chemical neuroanatomy

Published: July 19, 2023

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.

Journal: Cell communication and signaling : CCS

Published: May 02, 2023

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.

Journal: Cell death & disease

Published: March 22, 2022

TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway.

TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway.

Journal: Neurological research

Published: July 28, 2020

Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma.

Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma.

Journal: Frontiers in neuroscience

Published: June 30, 2020

Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling.

Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling.

Journal: Cancers

Published: September 13, 2019

Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization.

Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization.

Journal: Oncogene

Published: May 13, 2019

Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer.

Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer.

Journal: Oncogene

Published: April 12, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026